Mirae Asset Global ETFs Holdings’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
BH
AC
VCM
RA
WCM
BAM
Mirae Asset Global ETFs Holdings's ANGO Position: Q1 2026 in Review
Mirae Asset Global ETFs Holdings reduced its AngioDynamics (ANGO) stake by 3.8% in Q1 2026, selling an estimated $7.51K and leaving 17,554 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #2364.
Mirae Asset Global ETFs Holdings first reported a position in ANGO in Q2 2024 and has held it in 8 quarters since. The position peaked at $234K in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.
- Mirae Asset Global ETFs Holdings held 17,554 shares of AngioDynamics worth $200K as of Q1 2026.
- Mirae Asset Global ETFs Holdings sold 693 AngioDynamics shares in Q1 2026, an estimated $7.51K.
- AngioDynamics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2364 holding.
- Mirae Asset Global ETFs Holdings first reported a position in AngioDynamics in Q2 2024 and has held it in 8 quarters since.
- Mirae Asset Global ETFs Holdings's AngioDynamics position peaked at $234K in Q4 2025.
- 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.